ASPM and liver cancer: Kaplan–Meier analysis revealed that the expression of ASPM was significantly associated with overall survival of patients with liver cancer (P = 0.004), showing a median survival of >34.0 months in ASPM low‐expression group versus 24.4 months in the ASPM high‐expression group (Fig. 2G).